Takeda Pharmaceutical Company Limited (TAK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Takeda Pharmaceutical Company Limited, with annual and quarterly history.
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 45.54x | 66.33x | 45.02x | 21.41x | 23.68x | 16.79x |
| P/B Ratio | 1.19x | 1.03x | 0.89x | 1.07x | 0.96x | 1.22x |
| P/S Ratio | 1.94x | 1.56x | 1.52x | 1.69x | 1.53x | 1.97x |
| Profitability | ||||||
| Gross Margin | 51.1% | 65.5% | 66.4% | 69.1% | 69.0% | 68.9% |
| Operating Margin | 12.0% | 7.5% | 5.0% | 12.2% | 12.9% | 15.9% |
| Net Margin | 4.3% | 2.4% | 3.4% | 7.9% | 6.4% | 11.8% |
| EBITDA Margin | 28.0% | 26.4% | 26.8% | 31.9% | 33.2% | 30.8% |
| Liquidity | ||||||
| Current Ratio | 1.27x | 1.01x | 1.11x | 0.97x | 1.21x | 1.53x |
| Quick Ratio | 0.70x | 0.52x | 0.58x | 0.57x | 0.81x | 1.10x |
| Leverage | ||||||
| Debt/Equity | 0.63x | 0.65x | 0.67x | 0.69x | 0.76x | 0.90x |
YoY = year-over-year change. Source: FMP..